Ursodiol Tablet, Film Coated
FDA Label NDC 55154-2633

28 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Ursodiol (NDC 55154-2633). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2.1 general dosing information, 2.2 liver function tests, 2.3 scoring the ursodiol tablets 500 mg, 3 dosage forms and strengths, 4 contraindications, 5.1 abnormal liver function tests, 5.2 enteroliths in patients with risk for intestinal stenosis or stasis, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

NDC 55154-2633-0

URSODIOL TABLETS, USP

250 MG

10 TABLETS

250mg Bag Label (322b164b 3399 4863 Abd6 489173169b7c 00)

250mg Bag Label (322b164b 3399 4863 Abd6 489173169b7c 00)

* Please review the disclaimer below.